Treatment of patients with multiple myeloma with zoledronic acid for four years instead of two years decreases risk of progressive bone disease without increasing risk of osteonecrosis of the jaw

Gundesen MT; Fredrik H.  Schjesvold; Annette Juul Vangsted; Carsten Helleberg; Einar Haukas; Trine Silkjaer; Elena Todorescu; Bo Amdi Jensen; Tobias  Schmidt Slørdahl; Jon Thor Asmussen; Hareth Nahi; Anders Waage; Niels Abildgaard; Thomas Lund

doi:10.1097/01.HS9.0000970580.01478.5b

Treatment of patients with multiple myeloma with zoledronic acid for four years instead of two years decreases risk of progressive bone disease without increasing risk of osteonecrosis of the jaw

Gundesen MT
, Fredrik H. Schjesvold
, Annette Juul Vangsted
, Carsten Helleberg
, Einar Haukas
, Trine Silkjaer
, Elena Todorescu
, Bo Amdi Jensen
, Tobias Schmidt Slørdahl
, Jon Thor Asmussen
, Hareth Nahi
, Anders Waage
, Niels Abildgaard
, Thomas Lund

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	01478.5b
Tidsskrift	HemaSphere
Vol/bind	7
Udgave nummer	Suppl. 3
ISSN	2572-9241
DOI	https://doi.org/10.1097/01.HS9.0000970580.01478.5b
Status	Udgivet - 7. aug. 2023
Begivenhed	EHA 2023 Hybrid Conference - Frankfurt, Tyskland Varighed: 8. jun. 2023 → 11. jun. 2023

Konference

Konference	EHA 2023 Hybrid Conference
Land/Område	Tyskland
By	Frankfurt
Periode	08/06/2023 → 11/06/2023

Dokumenter og links

10.1097/01.HS9.0000970580.01478.5bLicens: CC BY-NC-ND

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

MT, G., Schjesvold, F. H., Vangsted, A. J., Helleberg, C., Haukas, E., Silkjaer, T., Todorescu, E., Jensen, B. A., Schmidt Slørdahl, T., Asmussen, J. T., Nahi, H., Waage, A., Abildgaard, N., & Lund, T. (2023). Treatment of patients with multiple myeloma with zoledronic acid for four years instead of two years decreases risk of progressive bone disease without increasing risk of osteonecrosis of the jaw. HemaSphere, 7(Suppl. 3), Artikel 01478.5b. https://doi.org/10.1097/01.HS9.0000970580.01478.5b

@article{799a78f8e88f4b31886a8e8e3edf0f78,

title = "Treatment of patients with multiple myeloma with zoledronic acid for four years instead of two years decreases risk of progressive bone disease without increasing risk of osteonecrosis of the jaw",

author = "Gundesen MT and Schjesvold, \{Fredrik H.\} and Vangsted, \{Annette Juul\} and Carsten Helleberg and Einar Haukas and Trine Silkjaer and Elena Todorescu and Jensen, \{Bo Amdi\} and \{Schmidt Sl{\o}rdahl\}, Tobias and Asmussen, \{Jon Thor\} and Hareth Nahi and Anders Waage and Niels Abildgaard and Thomas Lund",

year = "2023",

month = aug,

day = "7",

doi = "10.1097/01.HS9.0000970580.01478.5b",

language = "English",

volume = "7",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wiley",

number = "Suppl. 3",

note = "EHA 2023 Hybrid Conference ; Conference date: 08-06-2023 Through 11-06-2023",

}

MT, G, Schjesvold, FH, Vangsted, AJ, Helleberg, C, Haukas, E, Silkjaer, T, Todorescu, E, Jensen, BA, Schmidt Slørdahl, T, Asmussen, JT, Nahi, H, Waage, A, Abildgaard, N & Lund, T 2023, 'Treatment of patients with multiple myeloma with zoledronic acid for four years instead of two years decreases risk of progressive bone disease without increasing risk of osteonecrosis of the jaw', HemaSphere, bind 7, nr. Suppl. 3, 01478.5b. https://doi.org/10.1097/01.HS9.0000970580.01478.5b

Treatment of patients with multiple myeloma with zoledronic acid for four years instead of two years decreases risk of progressive bone disease without increasing risk of osteonecrosis of the jaw. / MT, Gundesen; Schjesvold, Fredrik H. ; Vangsted, Annette Juul et al.
I: HemaSphere, Bind 7, Nr. Suppl. 3, 01478.5b, 07.08.2023.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Treatment of patients with multiple myeloma with zoledronic acid for four years instead of two years decreases risk of progressive bone disease without increasing risk of osteonecrosis of the jaw

AU - MT, Gundesen

AU - Schjesvold, Fredrik H.

AU - Vangsted, Annette Juul

AU - Helleberg, Carsten

AU - Haukas, Einar

AU - Silkjaer, Trine

AU - Todorescu, Elena

AU - Jensen, Bo Amdi

AU - Schmidt Slørdahl, Tobias

AU - Asmussen, Jon Thor

AU - Nahi, Hareth

AU - Waage, Anders

AU - Abildgaard, Niels

AU - Lund, Thomas

PY - 2023/8/7

Y1 - 2023/8/7

U2 - 10.1097/01.HS9.0000970580.01478.5b

DO - 10.1097/01.HS9.0000970580.01478.5b

M3 - Conference abstract in journal

SN - 2572-9241

VL - 7

JO - HemaSphere

JF - HemaSphere

IS - Suppl. 3

M1 - 01478.5b

T2 - EHA 2023 Hybrid Conference

Y2 - 8 June 2023 through 11 June 2023

ER -